Navigation Links
Consortium develops new method to manipulate genetic material
Date:7/24/2008

MINNEAPOLIS / ST. PAUL (July 24, 2008) A multi-institutional team of researchers, including scientists at the University of Minnesota Medical School, have developed a powerful tool for genomic research and medicine. The robust method will allow researchers to generate synthetic enzymes that can target and manipulate DNA sequences for inactivation or repair.

The potential for discovery is great, said Dan Voytas, Ph.D., director of the Arnold and Mabel Beckman Center for Transposon Research, and co-investigator on the research. In human therapeutics, researchers may aim to correct genetic disorders or diseases, and in plants, scientists may devise crops that are more resistant to pathogens, yield more product, and better combat stress.

In the July 25 issue of Molecular Cell, researchers including Voytas describe an efficient method to induce specific genomic modifications in many types of cells including plants and humans. This is the first time the method will be publicly available and free to researchers.

"This method is going to be a turning point in the way we manipulate genomes," Voytas said. "It will allow any researcher to make a change to genetic material."

More specifically, the article shows researchers how to engineer customized zinc-finger nucleases (ZFNs), which can be used to induce specific genomic modifications in many types of cells.

"Recent work has shown that ZFNs can alter genes with high efficiency in cells from plants or model organisms like fruit flies, roundworms, and zebra fish, and in human cells," said J. Keith Joung, M.D., Ph.D., assistant professor of pathology at Harvard Medical School and director of the Molecular Pathology Unit at MGH, principal investigator of the study. "Our method will enable academic researchers to rapidly create high quality ZFNs for genes of interest and will stimulate use of this technology in biological research and potentially gene therapy."

Curr
'/>"/>

Contact: Nick Hanson
hans2853@umn.edu
612-624-2449
University of Minnesota
Source:Eurekalert

Page: 1 2

Related biology news :

1. NIH expands national consortium dedicated to transforming clinical and translational research
2. Midlands Consortium delighted to be chosen to host £1 billion energy institute
3. Hebrew University develops novel approach for treating mitochondrial disorders
4. Engineer develops detergent to promote peripheral nerve healing
5. Taking a cue from breath fresheners, researcher develops new method for taste testing
6. Carnegie Mellon develops computer model to study cell membrane dynamics
7. Queens develops safe green decontamination method
8. Europe develops new technologies to boost health of livestock
9. Scientists discover how TB develops invincibility against only available treatment
10. U of I researcher develops power-packed soy breakfast cereal
11. MBL develops infrastructure and portal for Encyclopedia of Life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... significant anti-tumour activity in patients with advanced BRAF ... has progressed after chemotherapy, according to phase II ... Madrid, Spain. , "Reports of lung cancers ... because these mutations may be associated with increased ... author Dr David Planchard, pulmonary oncologist at the ...
(Date:9/29/2014)... This news release is available in French . ... 29th, 2014 - The number of days an expectant ... (1998) predicts the epigenetic profile of her child, a ... University Institute and McGill University have detected a distinctive ... aftermath of the massive Quebec ice storm. Five months ...
(Date:9/29/2014)... Ill. Scientists have discovered a previously unknown ... grow and, in the case of estrogen-positive breast ... work reveals new targets for breast cancer therapy ... the most aggressive treatment. , The University of ... Oncogene . , Estrogen pre-activates the unfolded-protein ...
Breaking Biology News(10 mins):Promising results shown with targeted approaches in subsets of non-small cell lung cancer 2Promising results shown with targeted approaches in subsets of non-small cell lung cancer 3Scientists discover a new role for estrogen in the pathology of breast cancer 2
... This week, one of the world,s foremost scientific journals will ... University of Kansas showing that mountain rodents called marmots are ... change. The groundbreaking study, published in Nature ... timing can increase body weight and population size simultaneously in ...
... Bird observatories all over the world may benefit ... study the retinal structure of live birds of prey. ... Science article, researchers reveal unprecedented three-dimensional information about ... hawks and two owls using the non-invasive, powerful ...
... 21 July, 2010 (Vienna, Austria) -- Can HIV ... HIV persistence in infected persons was the topic of ... the eve of AIDS 2010, the biennial international conference ... workshop, "Towards a Cure: HIV Reservoirs and Strategies to ...
Cached Biology News:Climate change causes larger, more plentiful marmots, study shows 2High-resolution imaging expands vision research of live birds of prey 2Top scientists tackle the issue of HIV persistence 2
(Date:9/29/2014)... -- Research and Markets  has announced the addition ... Services, End-User , Application - Global Forecast to 2019" ... global oligonucleotide synthesis market is expected to reach $1,712.1 ... at a CAGR of 9.8% from 2014 to 2019. ... basis of products and services, applications, end users, and ...
(Date:9/29/2014)... batteries are efficient but involve a range of ... (lucerne seed) and pine resin and a clever ... with a highly interesting alternative. Their study will ... ChemSusChem . , ,We think our discovery can ... for the batteries of the future, says Daniel ...
(Date:9/29/2014)... Transparency Market Research, in its report titled ... by Application - Cancer, Metabolic, CVS, CNS & others, ... - Global Industry Analysis, Size, Share, Growth, Trends and ... therapeutics market was worth US$14.1 billion in 2011 and ... an 8.7% CAGR. , The two main types of ...
(Date:9/29/2014)... Burnham Securities Inc. ("Burnham"), a financial ... leader in healthcare venture development and strategic transactions ... expand the range of services each company can ... Securities will be supported by a team of ... in healthcare industry to build a healthcare franchise. ...
Breaking Biology Technology:Oligonucleotide Synthesis (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) Market - Global Forecast to 2019 2Oligonucleotide Synthesis (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) Market - Global Forecast to 2019 3Smart, eco-friendly new battery to solve problems 2Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 2Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 3Burnham Securities Inc. and The Channel Group Form Healthcare Alliance 2Burnham Securities Inc. and The Channel Group Form Healthcare Alliance 3
... MA (July 20, 2011)A consortium led by scientists at the ... world,s most detailed genetic map. A genetic map ... sperm or egg where the DNA from the mother and ... reproductive cell. The biological process whereby this reshuffling occurs is ...
... (Nasdaq: SGMO ) today announced that the company ... July 27, 2011, after the market closes. The press release ... ET, which will be open to the public via telephone ... the financial results and discuss other business matters. ...
... July 20, 2011 Regulus Therapeutics Inc ., ... innovative medicines targeting microRNAs, today announced that it has ... GlaxoSmithKline (GSK), triggering a preclinical milestone payment from GSK. ... its microRNA alliance with GSK, which is focused on ...
Cached Biology Technology:Researchers create the world's most advanced genetic map 2Researchers create the world's most advanced genetic map 3Sangamo BioSciences Announces Second Quarter 2011 Conference Call and Webcast 2Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 2Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 3Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 4
... The Rapid-Screen cDNA Library Panels were ... just three sets of PCRs to identify ... analysis is performed in a 96-well "Master ... from 5,000 clones. Having identified the positive ...
... The Rapid-Screen cDNA Library Panels were ... just three sets of PCRs to identify ... analysis is performed in a 96-well "Master ... from 5,000 clones. Having identified the positive ...
... II (Dual-Stage Quadrupole) Thermo Scientific (Part ... in analytical instrumentation, introduces the latest product ... II. Based on the proven reliability and ... GC/MS systems, the DSQ II incorporates the ...
... Panels were designed for full-length gene cloning ... to identify the desired cDNA clone. The ... 96-well "Master Plate," where each well contains ... the positive well(s) by gel electrophoresis of ...
Biology Products: